相关实验视频

Updated: Jan 9, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

多发性硬化症中的迷幻药物:神经免疫调节和修复的机制,挑战和前景

Ivan Anchesi¹, Maria Francesca Astorino², Ivana Raffaele¹

¹IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.

|December 10, 2025

概括

迷幻药可能通过减少神经炎症和促进神经修复,为多发性硬化症 (MS) 提供新的希望. 然而,目前的证据有限,这表明非幻觉性化合物是未来更有前途的治疗策略.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是一个学科.

背景情况:

目前的多发性硬化症 (MS) 治疗向外周免疫力,但缺乏神经修复能力.
对于促进神经炎症抑制和神经再生的药物,存在治疗缺口.

研究的目的:

通过激活5-HT2A受体来评估精神成像化合物 (PSYs) 对其通过激活5-HT2A受体来解决MS的潜力.
探索PSY是否可以同时减少神经炎症并增强中枢神经系统的神经修复.

主要方法:

对PSY对神经免疫环境的影响现有证据的审查.
分析PSY对促炎性细胞因子 (例如TNF-α,IL-6) 和神经营养因子 (例如BDNF) 的影响.
对转化障碍和潜在的治疗策略进行批判性评估.

主要成果:

PSYs显示出潜在的潜力,可以降低质细胞中促炎性细胞因子的调节.
PSYs可能会调高像BDNF这样的神经营养因子,支持突触可塑性和寡细胞功能.
来自非特异性炎症模型的证据不足以预测MS疗效.

结论:

对MS的PSY直接临床使用面临着显著的转化障碍 (心血管,精神病,法律,伦理).
PSYs的真正价值可能在于识别新的治疗途径.
由PSY药理学启发的非幻觉,选择性5-HT2A激动剂为MS治疗提供了更可行的策略,需要进一步的临床前验证.

关键词:

这就是为什么BDNF是BDNF.在HTR2A受体.状细胞是状细胞中的一种.多发性硬化症多发性硬化症神经炎症是一种神经炎症.神经可塑性神经可塑性迷幻化合物迷幻化合物治疗策略治疗策略

更多相关视频

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

相关概念视频

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...